LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,149
تعداد مقالات10,518
تعداد مشاهده مقاله45,415,438
تعداد دریافت فایل اصل مقاله11,291,231
Vejdani Afkham, B, Masjoodi, S, Vosoughi, R, Mosayebian, F, Yousef Pour, M. (1399). Exploring Two Methods of CBV Estimation in Two Groups of Grade III Gliomas with Different Appearance on Post-Contrast T1 Images. سامانه مدیریت نشریات علمی, 10(3), 283-290. doi: 10.31661/jbpe.v0i0.1176
B Vejdani Afkham; S Masjoodi; R Vosoughi; F Mosayebian; M Yousef Pour. "Exploring Two Methods of CBV Estimation in Two Groups of Grade III Gliomas with Different Appearance on Post-Contrast T1 Images". سامانه مدیریت نشریات علمی, 10, 3, 1399, 283-290. doi: 10.31661/jbpe.v0i0.1176
Vejdani Afkham, B, Masjoodi, S, Vosoughi, R, Mosayebian, F, Yousef Pour, M. (1399). 'Exploring Two Methods of CBV Estimation in Two Groups of Grade III Gliomas with Different Appearance on Post-Contrast T1 Images', سامانه مدیریت نشریات علمی, 10(3), pp. 283-290. doi: 10.31661/jbpe.v0i0.1176
Vejdani Afkham, B, Masjoodi, S, Vosoughi, R, Mosayebian, F, Yousef Pour, M. Exploring Two Methods of CBV Estimation in Two Groups of Grade III Gliomas with Different Appearance on Post-Contrast T1 Images. سامانه مدیریت نشریات علمی, 1399; 10(3): 283-290. doi: 10.31661/jbpe.v0i0.1176

Exploring Two Methods of CBV Estimation in Two Groups of Grade III Gliomas with Different Appearance on Post-Contrast T1 Images

Journal of Biomedical Physics and Engineering
مقاله 5، دوره 10، شماره 3، شهریور 2020، صفحه 283-290    اصل مقاله (765.77 K)
نوع مقاله: Original Research
شناسه دیجیتال (DOI): 10.31661/jbpe.v0i0.1176
نویسندگان
B Vejdani Afkham1؛ S Masjoodi2؛ R Vosoughi1؛ F Mosayebian3؛ M Yousef Pour* 4
1MSc, Department of Medical Physics and Biomedical Engineering, School of Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran
2PhD, Department of Medical Physics and Biomedical Engineering, School of Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran
3MSc, Department of radiology technology, School of Applied Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4PhD, School of Medicine, Aja university of Medical Science, Tehran, Iran
چکیده
Background: Many studies have used Cerebral Blood Volume (CBV) for gliomas grading and there has been in good agreement between CBV and tumor grade. Almost all of those studies have emphasized the importance of leakage correction due to the underestimation/overestimation of CBV caused by T1/T2* leakage effect in enhanced cases of tumors, especially high grade ones.
Objectives: The aim of this study is to investigate two methods of CBV estimation in two groups of gliomas with the same grade and different appearance on post contrast T1 images (Enhanced vs. Non-enhanced ones).
Material and Methods: In this retrospective study, eight glioma patients with histopatologically confirmed grade III were equally divided into two groups (with enhancement (group 1) and without enhancement (group 2)), and retrospectively studied. Imaging was performed on a 3 tesla MR Scanner and included gradient-echo DSC, 3D T1-weighted dataset and FLAIR images. The conventional method of CBV measurement (Integration over the whole curve of CTC- method 1) and the GVF fitting (method 2) was done using Matlab.
Results: The observed mean rCBV in the tumor ROI was 2.85 and 2.12 for group 1 with method 1 and 2, respectively. Mean rCBV in the tumor ROI for group 2 was 1.24 and 1.11 with method 1 and 2, respectively.
Conclusion: In conclusion, this pilot study demonstrated that with combined use of pre-bolus and accounting for T2* effect, CBV could be considered as a criterion for the categorization of glioma tumors.
کلیدواژه‌ها
Neoplasm Grading؛ Magnetic Resonance Imaging؛ Cerebral Blood Volume
سایر فایل های مرتبط با مقاله
مراجع
  1. Scott JN, Brasher PM, Sevick RJ, Rewcastle NB, Forsyth PA. How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology. 2002;59:947-9. doi: 10.1212/wnl.59.6.947. PubMed PMID: 12297589.
  2. Lee SJ, Kim JH, Kim YM, Lee GK, Lee EJ, Park IS, et al. Perfusion MR imaging in gliomas: comparison with histologic tumor grade. Korean J Radiol. 2001;2:1-7. doi: 10.3348/kjr.2001.2.1.1. PubMed PMID: 11752962.PubMed PMCID: PMC2718089.
  3. Shin JH, Lee HK, Kwun BD, Kim JS, Kang W, Choi CG, et al. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. AJR Am J Roentgenol. 2002;179:783-9. doi: 10.2214/ajr.179.3.1790783. PubMed PMID: 12185064.
  4. Kiselev VG. Effect of magnetic field gradients induced by microvasculature on NMR measurements of molecular self-diffusion in biological tissues. J Magn Reson. 2004;170:228-35. doi: 10.1016/j.jmr.2004.07.004. PubMed PMID: 15388085.
  5. Morita N, Wang S, Chawla S, Poptani H, Melhem ER. Dynamic susceptibility contrast perfusion weighted imaging in grading of nonenhancing astrocytomas. J Magn Reson Imaging. 2010;32:803-8. doi: 10.1002/jmri.22324. PubMed PMID: 20882610.
  6. Boxerman JL, Schmainda KM, Weisskoff RM. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol. 2006;27:859-67. PubMed PMID: 16611779.
  7. Kang HY, Xiao HL, Chen JH, Tan Y, Chen X, Xie T, et al. Comparison of the Effect of Vessel Size Imaging and Cerebral Blood Volume Derived from Perfusion MR Imaging on Glioma Grading. AJNR Am J Neuroradiol. 2016;37:51-7. doi: 10.3174/ajnr.A4477. PubMed PMID: 26381565.
  8. Paulson ES, Schmainda KM. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. Radiology. 2008;249:601-13. doi: 10.1148/radiol.2492071659. PubMed PMID: 18780827. PubMed PMCID: PMC2657863.
  9. Perkio J, Aronen HJ, Kangasmaki A, Liu Y, Karonen J, Savolainen S, et al. Evaluation of four postprocessing methods for determination of cerebral blood volume and mean transit time by dynamic susceptibility contrast imaging. Magn Reson Med. 2002;47:973-81. doi: 10.1002/mrm.10126. PubMed PMID: 11979577.
  10. Bjornerud A, Emblem KE, editors. Estimation of contrast agent extravasation from the tissue residue function: application to tumor perfusion imaging. Proceedings of the 17th Annual Meeting of International Society of Magnetic Resonance in Medicine; Honolulu: ISMRM; 2009.
  11. Bjornerud A, Sorensen AG, Mouridsen K, Emblem KE. T1- and T2*-dominant extravasation correction in DSC-MRI: part I--theoretical considerations and implications for assessment of tumor hemodynamic properties. J Cereb Blood Flow Metab. 2011;31:2041-53. doi: 10.1038/jcbfm.2011.52. PubMed PMID: 21505483.PubMed PMCID: PMC3208149.
  12. Boxerman JL, Paulson ES, Prah MA, Schmainda KM. The effect of pulse sequence parameters and contrast agent dose on percentage signal recovery in DSC-MRI: implications for clinical applications. AJNR Am J Neuroradiol. 2013;34:1364-9. doi: 10.3174/ajnr.A3477. PubMed PMID: 23413249. PubMed PMCID: PMC4316677.
  13. Law M, Yang S, Babb JS, Knopp EA, Golfinos JG, Zagzag D, et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol. 2004;25:746-55. PubMed PMID: 15140713.
  14. Essig M, Shiroishi MS, Nguyen TB, Saake M, Provenzale JM, Enterline D, et al. Perfusion MRI: the five most frequently asked technical questions. AJR Am J Roentgenol. 2013;200:24-34. doi: 10.2214/AJR.12.9543. PubMed PMID: 23255738. PubMed PMCID: PMC3593114.
  15. Hu LS, Baxter LC, Pinnaduwage DS, Paine TL, Karis JP, Feuerstein BG, et al. Optimized preload leakage-correction methods to improve the diagnostic accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in posttreatment gliomas. AJNR Am J Neuroradiol. 2010;31:40-8. doi: 10.3174/ajnr.A1787. PubMed PMID: 19749223. PubMed PMCID: PMC4323177.
  16. Sahin N, Melhem ER, Wang S, Krejza J, Poptani H, Chawla S, et al. Advanced MR imaging techniques in the evaluation of nonenhancing gliomas: perfusion-weighted imaging compared with proton magnetic resonance spectroscopy and tumor grade. Neuroradiol J. 2013;26:531-41. doi: 10.1177/197140091302600506. PubMed PMID: 24199813. PubMed PMCID: PMC4202829.
  17. Maia Jr AC, Malheiros SM, Da Rocha AJ, Da Silva CJ, Gabbai AA, Ferraz FA, et al. MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. AJNR Am J Neuroradiol. 2005;26:777-83. PubMed PMID: 15814920.
  18. Vejdani Afkham B, Masjoodi S, Oghabian MA, Ghodsi SR, Nazem Zadeh MR, Esmati E, Farzin M, Gilasi M, Hashemi H. Evaluation of contrast agent dose and diffusion coefficient measurement on vessel size index estimation. MAGMA. 2019;32(5):529-537. doi: 10.1007/s10334-019-00760-4. PubMed PMID: 31270714.
  19. Donahue KM, Krouwer HG, Rand SD, Pathak AP, Marszalkowski CS, Censky SC, et al. Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients. Magn Reson Med. 2000;43:845-53. doi: 10.1002/1522-2594(200006)43:63.3.co;2-a. PubMed PMID: 10861879.
  20. Fan G, Deng Q, Wu Z, Guo Q. Usefulness of diffusion/perfusion-weighted MRI in patients with non-enhancing supratentorial brain gliomas: a valuable tool to predict tumour grading? The British journal of radiology. 2006;79:652-8. doi: 10.1259/bjr/25349497.
  21. Falk A, Fahlström M, Rostrup E, Berntsson S, Zetterling M, Morell A, et al. Discrimination between glioma grades II and III in suspected low-grade gliomas using dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging: a histogram analysis approach. Neuroradiology. 2014;56:1031-8. doi: 10.1007/s00234-014-1426-z.
آمار
تعداد مشاهده مقاله: 1,560
تعداد دریافت فایل اصل مقاله: 621


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب